RASAYANA’s IN FEMALE INFERTILITY DUE TO METABOLIC DISORDERS

Abstract

Female infertility is defined as failure to conceive after frequent unprotected sexual intercourse for one or two years in couple who are in their reproductive age group. Metabolic Disorders reported in the reproductive age fall under a cluster of endocrine disturbances including PCOS, obesity, dyslipidaemia, and insulin resistance (Diabetes). Women with metabolic disorders are more common for infertility affecting 6% to 12% (as many as 5 million) women of reproductive age. Female infertility is raised to the alarming extent due to diet and lifestyle modifications. Over few past times, fertility treatment has expanded to Hormonal therapy, In vitro Fertilization i.e., IVF, Embryo Transfer i.e., ET, Gamete Intrafallopian Transfer i.e. GIFT etc are very expensive but they give unsatisfactory results along with lots of side effects like ovarian hyperstimulation, frequent abortion and major possibility of long-term ovarian cancer.